Searched for
BHARAT BIOTECH INTERNATIONAL LTD.
Ahead of Market: 10 things that will decide stock market action on ThursdayIndian equities lost momentum after a positive start, with Nifty closing lower and broader markets declining sharply. Investor caution ahea...- Tata Chemicals CEO R Mukundan takes over as CII president for 2026-27R Mukundan, CEO of Tata Chemicals, has assumed the presidency of the Confederation of Indian Industry (CII) for 2026-27, succeeding Rajiv M...
- Vaccine maker Bharat Biotech said to mull $500 million IPOIndian vaccine developer Bharat Biotech International Ltd. is considering an initial public offering that may raise more than $500 million,...
- Bharat Biotech signs MoU with University of Sydney to collaborate on vaccine researchBharat Biotech and the University of Sydney Infectious Diseases Institute (Sydney ID) have signed a memorandum of understanding to advance ...
- CCI approves Bharat Biotech International-Eastman Exports dealThe deal has been approved under the green channel route, wherein a transaction which does not raise any risk of an appreciable adverse eff...
- Bharat Biotech expects regulator's nod for intranasal COVID-19 vaccine in August"We will be applying for licenses and (they) should come. If everything goes well, we know by next month (August). You (people) would rathe...
- US asks Bharat Bio partner Ocugen to halt Covaxin trials"The company was informed by the USFDA that the agency placed its phase 2/3 immuno-bridging and broadening study for Covaxin (BBV152), OCU-...
- Bharat Biotech, IVI launch Chikungunya Vaccine Phase 2/3 trial in Costa RicaCEPI first partnered with IVI and Bharat Biotech in June 2020, providing up to USD 14.1 million for vaccine manufacturing and clinical deve...
- WHO has commenced review process for emergency use listing of Covaxin: GovtResponding to a question on whether it has come to the notice of the government that COVID-19 vaccine Covaxin used in India is not recognis...
- Bharat Biotech seeks nod for Covaxin in 60+ countriesThe countries that granted emergency use licences (EUL) include Mexico, Philippines, Iran, Paraguay, Guatemala, Nicaragua, Guyana, Venezuel...
- Covax seeks faster WHO approval for CovaxinIn a meeting held on Friday, Covax facility experts from India and other countries recommended approval for the India-developed Covaxin and...
- Covaxin can neutralise double mutant variantPhase 3 clinical trials of Covaxin by Bharat Biotech International Ltd (BBIL) and ICMR have demonstrated 100% efficacy against severe Covid...
- Bharat Biotech hails PM for taking COVID-19 vaccine, says it will give a huge boost to immunisation campaignHailing the Prime Minister for taking the vaccine on the first day, Chairman and Managing Director of Bharat Biotech International Limited ...
- Criticism mounts of India's 'abrupt' approval for Bharat Biotech's CovaxinThe recommendations of the Indian drugs regulator's subject expert committee (SEC) released on Tuesday show that the panel asked Bharat Bio...
- Over 60 foreign envoys visit leading pharma companies in HyderabadOver 60 foreign envoys on Wednesday visited Hyderabad-based leading biotech companies Bharat Biotech and Biological E where they were appri...
- Bharat Biotech's intranasal vaccine to enter phase I/II trials by month-endVaccine producer Bharat Biotech International (BBIL) could begin phase I/II human clinical trials for its single-dose intranasal vaccine ca...
- Bharat Biotech begins Phase-III trials for COVID-19 vaccine, Covaxin, with 26,000 volunteers"This is India's first phase-III efficacy study for a Covid-19 vaccine, and the largest phase-III efficacy trial ever conducted in India," ...
- Bharat Biotech to launch Covaxin in Q2 2021The company's vaccine candidate -Covaxin- has been developed in collaboration with the Indian Council of Medical Research (ICMR) - National...
- ICICI Ventures, IFC may exit Bharat Biotech; transaction may value company at 1000 croreInvestment banker Avendus has been mandated by ICICI Ventures to find suitors and the initial process has begun, sources in the know said.
- Bharat Biotech International launches 'Comvac5' vaccine for hepatitisHyderabad-based Bharat Biotech International said it has launched Comvac5, a single shot pentavalent combination vaccine for hepatitis.
Load More
